These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 33361430)
21. Inhibition of Antiviral Innate Immunity by Foot-and-Mouth Disease Virus L Sui C; Jiang D; Wu X; Liu S; Li F; Pan L; Cong X; Li J; Yoo D; Rock DL; Miller LC; Lee C; Du Y; Qi J J Virol; 2021 Jul; 95(15):e0036121. PubMed ID: 33980594 [TBL] [Abstract][Full Text] [Related]
22. The VP1 S154D mutation of type Asia1 foot-and-mouth disease virus enhances viral replication and pathogenicity. Lian K; Yang F; Zhu Z; Cao W; Jin Y; Liu H; Li D; Zhang K; Guo J; Liu X; Zheng H Infect Genet Evol; 2016 Apr; 39():113-119. PubMed ID: 26792712 [TBL] [Abstract][Full Text] [Related]
23. Foot-and-Mouth Disease Virus Counteracts on Internal Ribosome Entry Site Suppression by G3BP1 and Inhibits G3BP1-Mediated Stress Granule Assembly Ye X; Pan T; Wang D; Fang L; Ma J; Zhu X; Shi Y; Zhang K; Zheng H; Chen H; Li K; Xiao S Front Immunol; 2018; 9():1142. PubMed ID: 29887867 [TBL] [Abstract][Full Text] [Related]
24. Phosphorylation of NF-kappaB1/p105 by oncoprotein kinase Tpl2: implications for a novel mechanism of Tpl2 regulation. Babu GR; Jin W; Norman L; Waterfield M; Chang M; Wu X; Zhang M; Sun SC Biochim Biophys Acta; 2006 Feb; 1763(2):174-81. PubMed ID: 16448710 [TBL] [Abstract][Full Text] [Related]
25. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice. Yang B; Lan X; Li X; Yin X; Li B; Han X; Li Y; Zhang Z; Liu J Vaccine; 2008 Oct; 26(43):5477-83. PubMed ID: 18694793 [TBL] [Abstract][Full Text] [Related]
26. Foot-and-mouth disease virus induces lysosomal degradation of NME1 to impair p53-regulated interferon-inducible antiviral genes expression. Feng HH; Zhu ZX; Cao WJ; Yang F; Zhang XL; Du XL; Zhang KS; Liu XT; Zheng HX Cell Death Dis; 2018 Aug; 9(9):885. PubMed ID: 30158514 [TBL] [Abstract][Full Text] [Related]
27. Tumor Progression Locus 2 Promotes Induction of IFNλ, Interferon Stimulated Genes and Antigen-Specific CD8+ T Cell Responses and Protects against Influenza Virus. Kuriakose T; Tripp RA; Watford WT PLoS Pathog; 2015 Aug; 11(8):e1005038. PubMed ID: 26241898 [TBL] [Abstract][Full Text] [Related]
28. Foot-and-mouth disease virus infection suppresses autophagy and NF-кB antiviral responses via degradation of ATG5-ATG12 by 3C Fan X; Han S; Yan D; Gao Y; Wei Y; Liu X; Liao Y; Guo H; Sun S Cell Death Dis; 2017 Jan; 8(1):e2561. PubMed ID: 28102839 [TBL] [Abstract][Full Text] [Related]
29. 3Cpro of foot-and-mouth disease virus antagonizes the interferon signaling pathway by blocking STAT1/STAT2 nuclear translocation. Du Y; Bi J; Liu J; Liu X; Wu X; Jiang P; Yoo D; Zhang Y; Wu J; Wan R; Zhao X; Guo L; Sun W; Cong X; Chen L; Wang J J Virol; 2014 May; 88(9):4908-20. PubMed ID: 24554650 [TBL] [Abstract][Full Text] [Related]
30. Phosphorylation at Thr-290 regulates Tpl2 binding to NF-kappaB1/p105 and Tpl2 activation and degradation by lipopolysaccharide. Cho J; Tsichlis PN Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2350-5. PubMed ID: 15699325 [TBL] [Abstract][Full Text] [Related]
31. Foot-and-mouth disease virus induces autophagosomes during cell entry via a class III phosphatidylinositol 3-kinase-independent pathway. Berryman S; Brooks E; Burman A; Hawes P; Roberts R; Netherton C; Monaghan P; Whelband M; Cottam E; Elazar Z; Jackson T; Wileman T J Virol; 2012 Dec; 86(23):12940-53. PubMed ID: 22993157 [TBL] [Abstract][Full Text] [Related]
32. Cellular Vimentin Interacts with Foot-and-Mouth Disease Virus Nonstructural Protein 3A and Negatively Modulates Viral Replication. Ma X; Ling Y; Li P; Sun P; Cao Y; Bai X; Li K; Fu Y; Zhang J; Li D; Bao H; Chen Y; Li Z; Wang Y; Lu Z; Liu Z J Virol; 2020 Jul; 94(16):. PubMed ID: 32493819 [TBL] [Abstract][Full Text] [Related]
33. Synergetic Contributions of Viral VP1, VP3, and 3C to Activation of the AKT-AMPK-MAPK-MTOR Signaling Pathway for Seneca Valley Virus-Induced Autophagy. Song J; Hou L; Quan R; Wang D; Jiang H; Liu J J Virol; 2022 Jan; 96(2):e0155021. PubMed ID: 34757844 [TBL] [Abstract][Full Text] [Related]
34. The pH Stability of Foot-and-Mouth Disease Virus Particles Is Modulated by Residues Located at the Pentameric Interface and in the N Terminus of VP1. Caridi F; Vázquez-Calvo A; Sobrino F; Martín-Acebes MA J Virol; 2015 May; 89(10):5633-42. PubMed ID: 25762735 [TBL] [Abstract][Full Text] [Related]
35. Molecular Mechanisms of Foot-and-Mouth Disease Virus Targeting the Host Antiviral Response. Rodríguez Pulido M; Sáiz M Front Cell Infect Microbiol; 2017; 7():252. PubMed ID: 28660175 [TBL] [Abstract][Full Text] [Related]
36. Foot-and-Mouth Disease Virus Evades Innate Immune Response by 3C-Targeting of MDA5. Kim H; Kim AY; Choi J; Park SY; Park SH; Kim JS; Lee SI; Park JH; Park CK; Ko YJ Cells; 2021 Jan; 10(2):. PubMed ID: 33572945 [TBL] [Abstract][Full Text] [Related]
37. NLRP3 inflammasome activation by Foot-and-mouth disease virus infection mainly induced by viral RNA and non-structural protein 2B. Zhi X; Zhang Y; Sun S; Zhang Z; Dong H; Luo X; Wei Y; Lu Z; Dou Y; Wu R; Jiang Z; Weng C; Seong Seo H; Guo H RNA Biol; 2020 Mar; 17(3):335-349. PubMed ID: 31840571 [TBL] [Abstract][Full Text] [Related]
38. Foot-and-Mouth Disease Virus Leader Protease Cleaves G3BP1 and G3BP2 and Inhibits Stress Granule Formation. Visser LJ; Medina GN; Rabouw HH; de Groot RJ; Langereis MA; de Los Santos T; van Kuppeveld FJM J Virol; 2019 Jan; 93(2):. PubMed ID: 30404792 [TBL] [Abstract][Full Text] [Related]
39. Transient inhibition of foot-and-mouth disease virus replication by siRNAs silencing VP1 protein coding region. Lv K; Guo Y; Zhang Y; Wang K; Li K; Zhu Y; Sun S Res Vet Sci; 2009 Jun; 86(3):443-52. PubMed ID: 19062053 [TBL] [Abstract][Full Text] [Related]
40. The DEAD-Box RNA Helicase DDX1 Interacts with the Viral Protein 3D and Inhibits Foot-and-Mouth Disease Virus Replication. Xue Q; Liu H; Zeng Q; Zheng H; Xue Q; Cai X Virol Sin; 2019 Dec; 34(6):610-617. PubMed ID: 31359346 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]